MundiPharma & Han Wha Pharma signs co-marketing agreement of Gynobetadine

MundiPharma(CEO Myung-Sae Lee) and Han Wha Pharma(CEO Kyung-Rak Kim) announced on the 7^th of February that they signed a joint sales agreement of Gynobetadine Vag Supp(50 suppositories per package), the most well-known vaginitis treatment in Korea.

Under the agreement, Hwan Wha Pharma will take charge in distribution of the package of 50, which is applied to the national health insurance, to o...